Company

Rigor you can hold us to.

Ometz Partners is a mid-market and private equity advisory firm. We bring the standard of rigor the largest strategy firms are known for, and change the structure around it: the partner who scopes the work delivers it, at a fixed fee, measured against your own baseline, with part of our fee at risk where the work allows. Built for companies between $20M and $500M in revenue and the sponsors behind them.

Scope a Diagnostic How the Diagnostic works Run the Performance Radar

Why we exist

Where strategy stalls: between the plan and the operation.

Mid-market and PE-backed companies rarely lack a strategy. What they lack is the capacity to carry it through: senior time to redesign how the work is done, the discipline to measure it, and someone accountable when the plan meets the operation. Technology adds to that list rather than removing it. Adoption is now common; results at scale remain rare, as the published benchmarks below show.

Published benchmarks on adoption and scale, 2026

37%

of organizations surveyed can attribute any EBIT impact to their AI use, while 88% now use AI in at least one business function

McKinsey, The State of AI: Global Survey 2026 (1,719 respondents, published August 2026) (2026)

22%

of organizations have scaled AI across multiple business units or adopted an AI-first approach, while 85% of functional leaders plan to raise AI spending

Gartner survey, January to April 2026 (1,303 respondents, revenue of $50M or more), 1 September 2026 (2026)

Figures are third-party market benchmarks from the cited sources, not Ometz Partners client results. We share them so you can size the problem before we ever talk.

Ometz Partners exists to close that gap. We start from your numbers, agree what has to move, and do the work alongside your team until it moves. We work through private equity sponsors and their companies in health and wellness, and buy-and-build is our specialty.

Who we work with

Sponsors and their companies, in the sectors we know from the inside.

Private Equity

Health & Wellness: Value Chain

Health & Wellness: Care Platforms

Financial Services

How we work

How an engagement runs.

Scope

A short written request, then a conversation with the partner who would lead the work. If a Diagnostic is not the right first step, we say so.

Diagnose

Two to four weeks at a fixed fee: your baseline from your own systems, three improvement plays sized and priced, and a 90-day plan. The findings are yours.

Deliver

The plays you choose become fixed-scope programs with an owner, written targets and a weekly rhythm. Where the work allows, part of our fee is at risk against those targets.

Measure

Results are reported against the Diagnostic baseline, from sources you can audit, in the format your board or sponsor already uses.

Stay

The same partners stay through delivery, in the program or in an interim or fractional seat, until the result is in your numbers and your team runs it.

Principles

How we operate.

The partner who sells delivers

The person you meet in scoping leads the Diagnostic and stays accountable through the program. There is no handoff to a delivery team you have not met.

Fixed fee, priced plays

The Diagnostic is a plain fixed fee. Every play that follows carries its value, cost and risk in writing before anyone starts. We publish engagement models, never a rate card.

We share the risk of the plan we write

Every program is measured against the baseline set in the Diagnostic. Where the work allows, part of our fee is at risk against the targets we agree with you. If those measures do not move, that part is not invoiced.

Technology agnostic, by design

We recommend tools on fit and cost, build on the systems you already run where they work, and tell you when the answer is not new software. Where we resell a product or receive a referral fee, we tell you before you decide, and we show you the alternatives we considered.

Cited evidence, not invented claims

Every statistic we publish comes from third-party research, carries its source and is labeled as a market benchmark. We publish no client numbers, logos or testimonials.

Clear limits

We do not give investment, legal, tax or medical advice, and we never make clinical or supervisory decisions. Where our work involves protected health information, we sign a business associate agreement.

Working with us

Three ways to engage. No rate card.

The Diagnostic sets the scope and price of anything that follows. Questions before you write? contact@ometzpartners.com

Scope a Diagnostic Run the Performance Radar

Who we are

The people you will talk to.

Ometz Partners is led by its two co-founders. Seats and programs are staffed by them and by a vetted network of operators; Ometz Partners is the accountable partner in every case.

Marlos Barbosa

MD & Co-Founder

Marlos Barbosa has spent 20 years on the hard part of strategy: making it happen. He founded Othink, a management consulting firm focused on consumer goods, retail and chemicals, led it as CEO and sold it to Business Integration Partners (BIP), one of Europe's fastest-growing consulting and technology groups, where he went on to serve as CEO in Brazil.

In private equity he has held advisor, operating partner and board roles, originated the investment thesis for a PE-backed company, ran it as CEO and board member after the investment round, and led two add-on acquisitions. He has advised leadership teams across the health and wellness value chain.

At Ometz Partners he leads every Performance Diagnostic: where growth, margin, cost, speed or cash can move, measured against the company's own baseline. The partner who scopes the work stays accountable through delivery. He studied at the Kellogg School of Management, Northwestern University.

Guy Gotslak

MD & Co-Founder

Guy has spent more than 15 years helping companies run on their data. He co-founded a data and analytics consulting firm that grew to 120 people and was acquired by NGDATA, where he went on to lead global solutions for consumer-facing companies in financial services, banking, hospitality and retail.

Through his advisory practice he works with companies in financial services, healthcare and manufacturing on data strategy, CRM, marketing automation and business intelligence, and serves as a fractional CTO and COO to growing businesses.

At Ometz Partners he leads Technology Strategy & Deployment: mapping what a business needs, matching the tools that fit, and building and integrating them with governance and audit trails. He studied at the Kellogg School of Management, Northwestern University.

OMETZAI LLC, a Delaware limited liability company, doing business as Ometz Partners. An Ometz company. We work with clients remotely and on site, wherever they operate.

Next step

Start with a scoping conversation.

Tell us the question you want answered. A partner replies in writing with whether a Performance Diagnostic is the right first step, and says so if it is not.